Javed Butler, MD, MPH, MBA
Mr. Jackson ist neu in der Stadt: Das Bewältigen von Herausforderungen bei der Optimierung der RAASi-Therapie
Mr. Jackson ist neu in der Stadt: Das Bewältigen von Herausforderungen bei de...
Gregory Lewis, MD
Michael Böhm, MD, FESC
Josep Comin-Colet, MD, PhD
Clinical Implications of Managing Iron Deficiency from AFFIRM-AHF
Piotr Ponikowski, MD, PHD, FESC, FHFA
Gerasimos Filippatos, MD, FESC, FHFA
AHA 2020: Neue Erkenntnisse zu Eisenmangel und Herzinsuffizienz
AHA 2020: New Insights on Iron Deficiency and Heart Failure
Eliot Brinton, MD, FAHA, FNLA
Erin D. Michos, MD, MHS, FACC, FAHA, FASE
Prevention of ASCVD in Women Through Lipid Management in the New Era
Peter van der Meer, MD, PhD
Common Misconceptions About Iron Deficiency in Heart Failure and What to Do About It
Common Misconceptions About Iron Deficiency in Heart Failure and What to Do A...
James A. Underberg, MD, MS, FACP, FNLA
Update on ASCVD Risk Assessment and Management
Austin G. Stack, MBBCh, MD, MSc, FASN, FRCPI
Mikhail Kosiborod, MD
Management of Heart Failure: Time to Consider New Options?
Mr. Jackson Moves to Town: Overcoming Challenges to Optimizing RAASi Therapy
Robert J. Mentz, MD
Don’t Be Fooled: It’s Not Just Anemia, It’s Iron Deficiency
Ileana L. Piña, MD, MPH, FAHA, FACC
Giuseppe M.C. Rosano, MD, PhD, FESC, FHFA
Examining Heart Failure Management: How Can We Do Better?
Jennifer Caudle, DO
Nicole Bernard Washington, DO, MPH
Taking Care of Yourself While Taking Care of Others During COVID-19
Brian P. McDonough, MD, FAAFP
How Primary Care Clinicians on the Frontline Are Managing Patients During the COVID-19 Pandemic
How Primary Care Clinicians on the Frontline Are Managing Patients During the...
Matt Birnholz, MD
Joshua D. Lee MD, MSc
Opioid Use Disorder: Expanding Access to Treatment
Thomas C. Wright, Jr., MD
The HPV Data Is In — What Do the Newest Updates in Screening Mean For Your Patients?
The HPV Data Is In — What Do the Newest Updates in Screening Mean For Your Pa...
Leonard H. Calabrese, DO
John R. Tesser, MD
Pinpointing the Top Questions about Biosimilars in Rheumatology
